포비돈 시장 - 세계 산업 규모, 점유율, 동향, 기회, 예측 : 최종 용도별, 판매 채널별, 지역별, 경쟁(2021-2031년)

The global povidone market is projected to expand from USD 1.12 billion in 2025 to USD 1.55 billion by 2031, achieving a compound annual growth rate (CAGR) of 5.56%. Povidone, scientifically termed Polyvinylpyrrolidone, is a versatile synthetic polymer primarily serving as a binder, film former, and stabilizer across the pharmaceutical, personal care, and food sectors. This market's growth is fundamentally fueled by the significant expansion of the global generic drug industry, which requires high-purity excipients for effective tablet formulation and enhanced bioavailability. Additionally, the personal care sector contributes to this upward trend through increasing consumer demand for hair styling and skin care products that leverage povidone for its fixation and emulsion stabilization capabilities. This substantial industrial consumption is further corroborated by trade data, with pharmaceutical exports from major manufacturing hubs like India reaching USD 30.46 billion in 2025, thereby underscoring a consistent global need for crucial raw materials such as povidone. A considerable obstacle hindering the market's expansion stems from the intensifying complexity of regulatory compliance concerning excipient safety and supply chain transparency. Adherence to stringent international standards compels manufacturers to commit substantial capital towards developing advanced quality control infrastructure and purification technologies. This regulatory burden consequently acts as a financial barrier, squeezing operational margins and making market entry difficult for smaller producers who lack the necessary resources to absorb the increasing costs associated with meeting these rigorous pharmacopeial demands.

Market Driver

The primary catalyst for the povidone market is the ongoing expansion of the global pharmaceutical manufacturing sector, which demands high-performance binders and solubilizers for solid dosage forms. As the production of generic drugs continues to accelerate, manufacturers are increasingly dependent on polyvinylpyrrolidone to enhance the bioavailability of active pharmaceutical ingredients (APIs) that exhibit poor solubility. This escalating volume demand is clearly demonstrated by the financial outcomes of leading excipient producers; for instance, Ashland Inc. reported a six percent revenue growth in its pharmaceutical segment in the fourth quarter of fiscal year 2024, a direct result of increased sales volumes. To meet this sustained industrial requirement, major raw material suppliers like BASF SE are maintaining substantial operational capacities, with their Nutrition & Care segment, including pharmaceutical ingredients, reporting third-party sales of EUR 6.73 billion in 2024.

Concurrently, the increasing demand for functional ingredients within the personal care and cosmetics industries is also significantly propelling the market trajectory, especially for povidone's utility in hair styling fixatives and as emulsion stabilizers. Consumers are increasingly favoring high-performance formulations, which in turn compels brands to incorporate versatile polymers that deliver superior film-forming capabilities without leaving unwanted residue. This robust consumption trend is evident across major economic regions, with the European cosmetics and personal care market, as reported by Cosmetics Europe in July 2025, attaining a retail value of EUR 103.9 billion in 2024, thereby underscoring the sector's resilience and its ongoing need for crucial formulation polymers.

Market Challenge

A substantial barrier to the global povidone market is the growing complexity of regulatory compliance related to excipient safety and supply chain transparency. Manufacturers are increasingly obligated to allocate significant capital to advanced purification technologies and robust quality control infrastructure to adhere to stricter international pharmacopeial standards. This financial strain notably reduces operational margins, particularly impacting smaller-scale producers who often lack the financial capacity to absorb these escalating compliance expenditures. As a result, the market experiences a consolidation trend, with only well-capitalized entities capable of maintaining the requisite production standards, thereby restricting broader market entry and diminishing competitive vibrancy.

This regulatory pressure also creates a tangible downstream effect on the consumption of critical excipients such as povidone, which are essential for tablet binding and enhancing bioavailability. The strain on the pharmaceutical development pipeline is highlighted by recent industry figures; for instance, the Pharmaceutical Research and Manufacturers of America (PhRMA) reported a 70% decrease in small molecule development investments in 2025, following recent legislative and regulatory changes. This significant contraction in development activities directly translates into reduced demand for essential binders in solid dosage forms, consequently hindering the overall volume growth of the povidone market.

Market Trends

A significant market trend involves innovation in next-generation hydrogel and nanofiber wound care scaffolds, which is fueling specialized demand for povidone-iodine and cross-linked PVP polymers. As healthcare providers increasingly seek advanced solutions for managing chronic ulcers and surgical site infections, manufacturers are incorporating povidone into sophisticated matrices designed for controlled antiseptic release and effective moisture management. This represents a strategic pivot from conventional antiseptics towards bioactive healing systems, where the polymer functions as a vital scaffold component. The commercial success of these cutting-edge systems is underscored by the strong performance of leading medtech divisions; for example, Smith+Nephew's Advanced Wound Management business unit recorded an underlying revenue growth of 12.2 percent in the fourth quarter of 2024, propelled by the widespread adoption of infection management and bioactive therapies.

Another notable trend is the industry's transition towards bio-based precursors and green manufacturing processes, which is actively reshaping the supply chain in response to growing concerns over carbon footprints. Suppliers are progressively substituting fossil-based feedstocks, such as acetylene and formaldehyde, with renewable biomass-balanced alternatives for the production of N-vinylpyrrolidone, which is the crucial monomer for povidone. This approach effectively lowers the cradle-to-gate carbon impact of the finished excipient, without compromising its chemical structure or regulatory standing, thereby appealing to sustainability-focused pharmaceutical and cosmetic brands. The positive environmental impact of this strategic shift is quantifiable: BASF SE's portfolio of biomass-balanced products, for instance, prevented approximately 8 million kilograms of CO2 emissions in 2024, demonstrating the significant industrial adoption of sustainable chemical intermediates.

Key Market Players

• Ashland Inc
• BASF SE
• Boai NKY Pharmaceuticals Ltd
• Glide Chem Private Limited
• Hangzhou Motto Science & Technology Co. Ltd
• JH Nanhang Life Sciences Co.,Ltd.
• Sichuan Tianhua Chemical Group Co. Ltd.
• Thermo Fisher Scientific Inc.

Report Scope

In this report, the Global Povidone Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Povidone Market, By End-Use Application

• Pharmaceutical
• Food & Beverages
• Personal Care & Cosmetics
• Adhesives
• Others

Povidone Market, By Sales Channel

• Direct Sale
• Indirect Sale

Povidone Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Povidone Market.

Available Customizations:

Global Povidone Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Povidone Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By End-Use Application (Pharmaceutical, Food & Beverages, Personal Care & Cosmetics, Adhesives, Others)
  • 5.2.2. By Sales Channel (Direct Sale, Indirect Sale)
  • 5.2.3. By Region
  • 5.2.4. By Company (2025)
• 5.3. Market Map

6. North America Povidone Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By End-Use Application
  • 6.2.2. By Sales Channel
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Povidone Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By End-Use Application
      • 6.3.1.2.2. By Sales Channel
  • 6.3.2. Canada Povidone Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By End-Use Application
      • 6.3.2.2.2. By Sales Channel
  • 6.3.3. Mexico Povidone Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By End-Use Application
      • 6.3.3.2.2. By Sales Channel

7. Europe Povidone Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By End-Use Application
  • 7.2.2. By Sales Channel
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Povidone Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By End-Use Application
      • 7.3.1.2.2. By Sales Channel
  • 7.3.2. France Povidone Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By End-Use Application
      • 7.3.2.2.2. By Sales Channel
  • 7.3.3. United Kingdom Povidone Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By End-Use Application
      • 7.3.3.2.2. By Sales Channel
  • 7.3.4. Italy Povidone Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By End-Use Application
      • 7.3.4.2.2. By Sales Channel
  • 7.3.5. Spain Povidone Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By End-Use Application
      • 7.3.5.2.2. By Sales Channel

8. Asia Pacific Povidone Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By End-Use Application
  • 8.2.2. By Sales Channel
  • 8.2.3. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Povidone Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By End-Use Application
      • 8.3.1.2.2. By Sales Channel
  • 8.3.2. India Povidone Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By End-Use Application
      • 8.3.2.2.2. By Sales Channel
  • 8.3.3. Japan Povidone Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By End-Use Application
      • 8.3.3.2.2. By Sales Channel
  • 8.3.4. South Korea Povidone Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By End-Use Application
      • 8.3.4.2.2. By Sales Channel
  • 8.3.5. Australia Povidone Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By End-Use Application
      • 8.3.5.2.2. By Sales Channel

9. Middle East & Africa Povidone Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By End-Use Application
  • 9.2.2. By Sales Channel
  • 9.2.3. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Povidone Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By End-Use Application
      • 9.3.1.2.2. By Sales Channel
  • 9.3.2. UAE Povidone Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By End-Use Application
      • 9.3.2.2.2. By Sales Channel
  • 9.3.3. South Africa Povidone Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By End-Use Application
      • 9.3.3.2.2. By Sales Channel

10. South America Povidone Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By End-Use Application
  • 10.2.2. By Sales Channel
  • 10.2.3. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Povidone Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By End-Use Application
      • 10.3.1.2.2. By Sales Channel
  • 10.3.2. Colombia Povidone Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By End-Use Application
      • 10.3.2.2.2. By Sales Channel
  • 10.3.3. Argentina Povidone Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By End-Use Application
      • 10.3.3.2.2. By Sales Channel

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Povidone Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Ashland Inc
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. BASF SE
• 15.3. Boai NKY Pharmaceuticals Ltd
• 15.4. Glide Chem Private Limited
• 15.5. Hangzhou Motto Science & Technology Co. Ltd
• 15.6. JH Nanhang Life Sciences Co.,Ltd.
• 15.7. Sichuan Tianhua Chemical Group Co. Ltd.
• 15.8. Thermo Fisher Scientific Inc.

16. Strategic Recommendations

17. About Us & Disclaimer